Nigeria Ventricular Assist Device Market

The Nigeria Ventricular Assist Device Market was valued at USD XX million in 2017, and is projected to reach USD XX million by 2025, growing at a CAGR of 7.4 % during 2018-2025.

Figure 1: Nigeria Ventricular Assist Device Market Revenue, 2018–2025 (USD Million)

Source: GMI Research

Increase in incidence of patients with heart failure, high prevalence of cardiac diseases and shortage of heart donors are the key factors driving the growth of the market. Moreover, the technically advanced VAD (DuraHeart, HeartMate III) are devices that further fuel the market growth.

Implantable design segment is expected to lead the market in the design segment during 2018–2025
Implantable design segment is expected to hold maximum market share in the market during the forecast period on account of wide awareness regarding the product in the field of interventional cardiology and cost effectiveness. Transcutaneous design type is also expected to witness strong growth due to the higher demand and high adoption by healthcare surgeons

Bridge-to-transplant (BTT) Therapy is anticipated to lead the market in the application segment during 2018–2025
Bridge-to-transplant (BTT) Therapy segment is expected to capture the largest market share in the market during the forecast due to shortage of heart donors. However, the highest growth rate is predicted to be exhibited by Bridge-to-recovery (BTR) Therapy segment in upcoming few years due to rise in product launches and collaboration between manufactures and healthcare facilities such as hospital, surgical centers. Increase in heart donors over the forecast period will result in the high growth rate of Bridge-to-recovery application.

Various notable players operating in Nigeria Ventricular Assist Device Market include Grafil Medical Limited, Coscharis Medical, Bijo Surgical & Scientific Co. Ltd., Bolsboy International Limited, Oakmed Continental Nigeria Ltd., Abbott Healthcare, May & Baker Nigeria Plc, Biotec Laboratory Products Nigeria, Kenny Medicals and OrthoEx Nigeria Limited among others.

The Nigeria Ventricular Assist Device market has been segmented on the basis of Application, Type and Design Segmentation. Based on Application type, the market comprises of Bridge-to-transplant (BTT) Therapy, Destination Therapy and Bridge-to-recovery (BTR) Therapy. The Product type includes Left Ventricular, Right Ventricular and Biventricular Assist Device.

The research report “Nigeria Ventricular Assist Device Market” provides in-depth analysis of the Ventricular Assist Device market, Nigeria, based on application type, product type and design type for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for Ventricular Assist Device Market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:

• •    At what pace is the Ventricular Assist Device Market growing worldwide? What will be the growth trend in future?
  •    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the coming years?
  •    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in Nigeria Robotic Surgical market?
  •   What are the various application areas and how they are poised to grow?